☰

David B. Bregman - Publications

Affiliations: 
Yeshiva University, New York, NY, United States 
Area:
Molecular Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Bregman DB, Goodnough LT. Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia. Therapeutic Advances in Hematology. 5: 48-60. PMID 24688754 DOI: 10.1177/2040620714521127  0.415
2014 Onken JE, Bregman DB, Harrington RA, Morris D, Buerkert J, Hamerski D, Iftikhar H, Mangoo-Karim R, Martin ER, Martinez CO, Newman GE, Qunibi WY, Ross DL, Singh B, Smith MT, et al. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 29: 833-42. PMID 23963731 DOI: 10.1093/Ndt/Gft251  0.416
2014 Onken JE, Bregman DB, Harrington RA, Morris D, Acs P, Akright B, Barish C, Bhaskar BS, Smith-Nguyen GN, Butcher A, Koch TA, Goodnough LT. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion. 54: 306-15. PMID 23772856 DOI: 10.1111/Trf.12289  0.4
2013 Hussain I, Bhoyroo J, Butcher A, Koch TA, He A, Bregman DB. Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia. Anemia. 2013: 169107. PMID 24069536 DOI: 10.1155/2013/169107  0.402
2013 Malone M, Barish C, He A, Bregman D. Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastric surgery patients. Obesity Surgery. 23: 1413-20. PMID 23553506 DOI: 10.1007/S11695-013-0939-6  0.385
2013 Wolf M, Koch TA, Bregman DB. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 1793-803. PMID 23505057 DOI: 10.1002/Jbmr.1923  0.385
2013 Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. American Journal of Hematology. 88: 97-101. PMID 23335357 DOI: 10.1182/Blood.V120.21.484.484  0.388
2013 Charytan C, Bernardo MV, Koch TA, Butcher A, Morris D, Bregman DB. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 28: 953-64. PMID 23222534 DOI: 10.1093/Ndt/Gfs528  0.382
2012 Barish CF, Koch T, Butcher A, Morris D, Bregman DB. Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials. Anemia. 2012: 172104. PMID 22997572 DOI: 10.1155/2012/172104  0.417
2011 Allen RP, Adler CH, Du W, Butcher A, Bregman DB, Earley CJ. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. Sleep Medicine. 12: 906-13. PMID 21978726 DOI: 10.1016/J.Sleep.2011.06.009  0.387
2011 Barish C, Bregman D, Butcher A, Koch T, Morris D. Safety and Efficacy of High Dose Intravenous Ferric Carboxymaltose vs. Standard Medical Care in the Treatment of Iron Deficiency Anemia: 1091 The American Journal of Gastroenterology. 106. DOI: 10.14309/00000434-201110002-01091  0.359
2010 Szczech LA, Bregman DB, Harrington RA, Morris D, Butcher A, Koch TA, Goodnough LT, Wolf M, Onken JE. Randomized Evaluation of efficacy and safety of ferric carboxymaltose in Patients with iron deficiency Anaemia and Impaired Renal function (REPAIR-IDA): Rationale and study design Nephrology Dialysis Transplantation. 25: 2368-2375. PMID 20466657 DOI: 10.1093/Ndt/Gfq218  0.393
Show low-probability matches.